Lotus Herbals has acquired a 32% strategic stake in Fixderma India Pvt Ltd – owners of the Fixderma and FCL brands of Dermaceuticals. Following this acquisition, the Lotus has entered the Dermaceutical segment that offers premium range of skincare and haircare products.

D2C brand Fixderma’s product lines get retailed through dermatologists and pharmacies in India and overseas. Their focus is on researching, manufacturing and marketing innovative dermatology products. They also work in tandem with dermatologists in India.

With this acquisition, Lotus Herbal’s vision is to emerge as the domain leader in the future. They plan on maintaining a distinctive brand identity for Fixderma and FCL in domestic and international markets while strategizing the brand expansion.

Lotus Herbals Joint MD Nitin Passi stated that with their strategic planning and marketing expertise, they are aiming at enhancing the global footprint for Fixderma and FCL and capturing significant market share within the next five years as part of their long-term growth strategy.